Literature DB >> 31349348

Earlier time to hemostasis is associated with decreased mortality and rate of complications: Results from the Pragmatic Randomized Optimal Platelet and Plasma Ratio trial.

Ronald Chang1, Jeffrey D Kerby, Kyle J Kalkwarf, Gerald Van Belle, Erin E Fox, Bryan A Cotton, Mitchell J Cohen, Martin A Schreiber, Karen Brasel, Eileen M Bulger, Kenji Inaba, Sandro Rizoli, Jeanette M Podbielski, Charles E Wade, John B Holcomb.   

Abstract

BACKDROP: Clinicians intuitively recognize that faster time to hemostasis is important in bleeding trauma patients, but these times are rarely reported.
METHODS: Prospectively collected data from the Pragmatic Randomized Optimal Platelet and Plasma Ratios trial were analyzed. Hemostasis was predefined as no intraoperative bleeding requiring intervention in the surgical field or resolution of contrast blush on interventional radiology (IR). Patients who underwent an emergent (within 90 minutes) operating room (OR) or IR procedure were included. Mixed-effects Poisson regression with robust error variance (controlling for age, Injury Severity Score, treatment arm, injury mechanism, base excess on admission [missing values estimated by multiple imputation], and time to OR/IR as fixed effects and study site as a random effect) with modified Bonferroni corrections tested the hypothesis that decreased time to hemostasis was associated with decreased mortality and decreased incidence of acute kidney injury (AKI), acute respiratory distress syndrome (ARDS), multiple-organ failure (MOF), sepsis, and venous thromboembolism.
RESULTS: Of 680 enrolled patients, 468 (69%) underwent an emergent procedure. Patients with decreased time to hemostasis were less severely injured, had less deranged base excess on admission, and lower incidence of blunt trauma (all p < 0.05). In 408 (87%) patients in whom hemostasis was achieved, every 15-minute decrease in time to hemostasis was associated with decreased 30-day mortality (RR, 0.97; 95% confidence interval [CI], 0.94-0.99), AKI (RR, 0.97; 95% CI, 0.96-0.98), ARDS (RR, 0.98; 95% CI, 0.97-0.99), MOF (RR, 0.94; 95% CI, 0.91-0.97), and sepsis (RR, 0.98; 95% CI, 0.96-0.99), but not venous thromboembolism (RR, 0.99; 95% CI, 0.96-1.03).
CONCLUSION: Earlier time to hemostasis was independently associated with decreased incidence of 30-day mortality, AKI, ARDS, MOF, and sepsis in bleeding trauma patients. Time to hemostasis should be considered as an endpoint in trauma studies and as a potential quality indicator. LEVEL OF EVIDENCE: Therapeutic/care management, level III.

Entities:  

Mesh:

Year:  2019        PMID: 31349348      PMCID: PMC6771437          DOI: 10.1097/TA.0000000000002263

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  24 in total

1.  Current opinion on catheter-based hemorrhage control in trauma patients.

Authors:  John B Holcomb; Erin E Fox; Thomas M Scalea; Lena M Napolitano; Rondel Albarado; Brijesh Gill; Brian J Dunkin; Andrew W Kirkpatrick; Bryan A Cotton; Kenji Inaba; Joseph J DuBose; Alan M Cohen; Ali Azizzadeh; Megan Brenner; Mitchell J Cohen; Charles E Wade; Alan B Lumsden; Richard Andrassy; Peter M Rhee; Barbara L Bass; Kenneth L Mattox; L D Britt; A Brent Eastman; David B Hoyt; Todd E Rasmussen
Journal:  J Trauma Acute Care Surg       Date:  2014-03       Impact factor: 3.313

Review 2.  Optimal Fluid Therapy for Traumatic Hemorrhagic Shock.

Authors:  Ronald Chang; John B Holcomb
Journal:  Crit Care Clin       Date:  2017-01       Impact factor: 3.598

3.  Trends in 1029 trauma deaths at a level 1 trauma center: Impact of a bleeding control bundle of care.

Authors:  Blessing T Oyeniyi; Erin E Fox; Michelle Scerbo; Jeffrey S Tomasek; Charles E Wade; John B Holcomb
Journal:  Injury       Date:  2016-11-03       Impact factor: 2.586

4.  Mortality after emergent trauma laparotomy: A multicenter, retrospective study.

Authors:  John A Harvin; Tom Maxim; Kenji Inaba; Myriam A Martinez-Aguilar; David R King; Asad J Choudhry; Martin D Zielinski; Sam Akinyeye; S Rob Todd; Russell L Griffin; Jeffrey D Kerby; Joanelle A Bailey; David H Livingston; Kyle Cunningham; Deborah M Stein; Lindsay Cattin; Eileen M Bulger; Alison Wilson; Vicente J Undurraga Perl; Martin A Schreiber; Jill R Cherry-Bukowiec; Hasan B Alam; John B Holcomb
Journal:  J Trauma Acute Care Surg       Date:  2017-09       Impact factor: 3.313

5.  How I treat patients with massive hemorrhage.

Authors:  Pär I Johansson; Jakob Stensballe; Roberto Oliveri; Charles E Wade; Sisse R Ostrowski; John B Holcomb
Journal:  Blood       Date:  2014-10-07       Impact factor: 22.113

6.  Eliminating preventable death on the battlefield.

Authors:  Russ S Kotwal; Harold R Montgomery; Bari M Kotwal; Howard R Champion; Frank K Butler; Robert L Mabry; Jeffrey S Cain; Lorne H Blackbourne; Kathy K Mechler; John B Holcomb
Journal:  Arch Surg       Date:  2011-08-15

7.  Earlier Endpoints are Required for Hemorrhagic Shock Trials Among Severely Injured Patients.

Authors:  Erin E Fox; John B Holcomb; Charles E Wade; Eileen M Bulger; Barbara C Tilley
Journal:  Shock       Date:  2017-05       Impact factor: 3.454

8.  Damage-control resuscitation and emergency laparotomy: Findings from the PROPPR study.

Authors:  Vicente J Undurraga Perl; Brian Leroux; Mackenzie R Cook; Justin Watson; Kelly Fair; David T Martin; Jeffrey D Kerby; Carolyn Williams; Kenji Inaba; Charles E Wade; Bryan A Cotton; Deborah J Del Junco; Erin E Fox; Thomas M Scalea; Barbara C Tilley; John B Holcomb; Martin A Schreiber
Journal:  J Trauma Acute Care Surg       Date:  2016-04       Impact factor: 3.313

9.  The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks.

Authors:  John B Holcomb; Deborah J del Junco; Erin E Fox; Charles E Wade; Mitchell J Cohen; Martin A Schreiber; Louis H Alarcon; Yu Bai; Karen J Brasel; Eileen M Bulger; Bryan A Cotton; Nena Matijevic; Peter Muskat; John G Myers; Herb A Phelan; Christopher E White; Jiajie Zhang; Mohammad H Rahbar
Journal:  JAMA Surg       Date:  2013-02       Impact factor: 14.766

10.  Epidemiology of trauma deaths: a reassessment.

Authors:  A Sauaia; F A Moore; E E Moore; K S Moser; R Brennan; R A Read; P T Pons
Journal:  J Trauma       Date:  1995-02
View more
  12 in total

Review 1.  The Diagnosis and Treatment of Acute Traumatic Bleeding and Coagulopathy.

Authors:  Marc Maegele
Journal:  Dtsch Arztebl Int       Date:  2019-11-22       Impact factor: 5.594

2.  VIBe Scale: Validation of the Intraoperative Bleeding Severity Scale by Spine Surgeons.

Authors:  Daniel M Sciubba; Nitin Khanna; Zach Pennington; Rahul K Singh
Journal:  Int J Spine Surg       Date:  2022-07-13

3.  Variations in clot phenotype following injury: The MA-R ratio and fragile clots.

Authors:  James Harrington; Ben L Zarzaur; Erin E Fox; Charles E Wade; John B Holcomb; Stephanie A Savage
Journal:  J Trauma Acute Care Surg       Date:  2022-03-01       Impact factor: 3.697

4.  Impact of a streamlined trauma management approach and determinants of mortality among hemodynamically unstable patients with severe multiple injuries: a before-and-after retrospective cohort study.

Authors:  Hiroyuki Otsuka; Atsushi Uehata; Naoki Sakoda; Toshiki Sato; Keiji Sakurai; Hiromichi Aoki; Takeshi Yamagiwa; Shinichi Iizuka; Sadaki Inokuchi
Journal:  Trauma Surg Acute Care Open       Date:  2020-09-25

5.  Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus Conference.

Authors:  Philip C Spinella; Nahed El Kassar; Andrew P Cap; Andrei L Kindzelski; Christopher S Almond; Alan Barkun; Terry B Gernsheimer; Joshua N Goldstein; John B Holcomb; Alfonso Iorio; Dennis M Jensen; Nigel S Key; Jerrold H Levy; Stephan A Mayer; Ernest E Moore; Simon J Stanworth; Roger J Lewis; Marie E Steiner
Journal:  J Trauma Acute Care Surg       Date:  2021-08-01       Impact factor: 3.697

6.  The European Perspective on the Management of Acute Major Hemorrhage and Coagulopathy after Trauma: Summary of the 2019 Updated European Guideline.

Authors:  Marc Maegele
Journal:  J Clin Med       Date:  2021-01-19       Impact factor: 4.241

7.  Clinical impact of a prehospital trauma shock bundle of care in South Africa.

Authors:  Nee-Kofi Mould-Millman; Julia M Dixon; Bradley van Ster; Fabio Moreira; Beatrix Bester; Charmaine Cunningham; Shaheem de Vries; Brenda Beaty; Krithika Suresh; Steven G Schauer; Joseph K Maddry; Lee A Wallis; Vikhyat S Bebarta; Adit A Ginde
Journal:  Afr J Emerg Med       Date:  2021-12-28

8.  Importance of duration of acute kidney injury after severe trauma: a cohort study.

Authors:  Gabrielle E Hatton; John A Harvin; Charles E Wade; Lillian S Kao
Journal:  Trauma Surg Acute Care Open       Date:  2021-05-27

9.  Role of POC INR in the early stage of diagnosis of coagulopathy.

Authors:  Florian J Raimann; Marie-Louise Lindner; Christoph Martin; Lukas Jennewein; Thomas Lustenberger; Florian Piekarski; Kai Zacharowski; Christian F Weber
Journal:  Pract Lab Med       Date:  2021-05-23

10.  Characteristics of Trauma Mortality in Patients with Aortic Injury in Harris County, Texas.

Authors:  Ronald Chang; Stacy A Drake; John B Holcomb; Garrett Phillips; Charles E Wade; Kristofer M Charlton-Ouw
Journal:  J Clin Med       Date:  2020-09-14       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.